Get complete Patent Opposition Report for Debiopharm

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Debiopharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2500014Feb 19, 2025Slow Release Pharmaceutical Composition Made Of Microparticles2
EP3728313Oct 25, 2023Combination Anti Cancer Therapy With An Iap Antagonist And An Anti Pd-1 Molecule2